Literature DB >> 26349943

Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes.

Eivind Valen Egeland1, Kjetil Boye2,3, Solveig J Pettersen2, Mads H Haugen2, Tove Øyjord2, Lene Malerød4, Kjersti Flatmark2,5,6, Gunhild M Mælandsmo7,8.   

Abstract

S100A4 promotes metastasis in several types of cancer, but the involved molecular mechanisms are still incompletely described. The protein is associated with a wide variety of biological functions and it locates to different subcellular compartments, including nuclei, cytoplasm and extracellular space. Nuclear expression of S100A4 has been associated with more advanced disease stage as well as poor outcome in colorectal cancer (CRC). The present study was initiated to investigate the nuclear function of S100A4 and thereby unravel potential biological mechanisms linking nuclear expression to a more aggressive phenotype. CRC cell lines show heterogeneity in nuclear S100A4 expression and preliminary experiments revealed cells in G2/M to have increased nuclear accumulation compared to G1 and S cells, respectively. Synchronization experiments validated nuclear S100A4 expression to be most prominent in the G2/M phase, but manipulating nuclear levels of S100A4 using lentiviral modified cells failed to induce changes in cell cycle distribution and proliferation. Proximity ligation assay did, however, demonstrate proximity between S100A4 and cyclin B1 in vitro, while confocal microscopy showed S100A4 to localize to areas corresponding to centrosomes in mitotic cells prior to chromosome segregation. This might indicate a novel and uncharacterized function of the metastasis-associated protein in CRC cells.

Entities:  

Keywords:  Cell cycle; Centrosomes; Colorectal cancer; Cyclin B1; Nucleus; S100A4

Mesh:

Substances:

Year:  2015        PMID: 26349943     DOI: 10.1007/s10585-015-9742-1

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  53 in total

1.  An update of the S100 nomenclature.

Authors:  Ingo Marenholz; Ruth C Lovering; Claus W Heizmann
Journal:  Biochim Biophys Acta       Date:  2006-07-26

2.  S100A4 interacts with p53 in the nucleus and promotes p53 degradation.

Authors:  L M Orre; E Panizza; V O Kaminskyy; E Vernet; T Gräslund; B Zhivotovsky; J Lehtiö
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

3.  p53 regulates a G2 checkpoint through cyclin B1.

Authors:  S A Innocente; J L Abrahamson; J P Cogswell; J M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma.

Authors:  Gisle Berge; Daniela Elena Costea; Marianne Berg; Heidi Rasmussen; Ida Grotterød; Ragnhild A Lothe; Gunhild M Mælandsmo; Kjersti Flatmark
Journal:  Amino Acids       Date:  2010-02-27       Impact factor: 3.520

5.  Nuclear S100A4 is a novel prognostic marker in colorectal cancer.

Authors:  Kjetil Boye; Jahn M Nesland; Berit Sandstad; Gunhild M Mælandsmo; Kjersti Flatmark
Journal:  Eur J Cancer       Date:  2010-08-16       Impact factor: 9.162

6.  The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence.

Authors:  Leyuan Bao; Adam F Odell; Sam L Stephen; Stephen B Wheatcroft; John H Walker; Sreenivasan Ponnambalam
Journal:  FEBS J       Date:  2012-11-22       Impact factor: 5.542

7.  The basic C-terminal amino acids of calcium-binding protein S100A4 promote metastasis.

Authors:  Thamir M Ismail; David G Fernig; Philip S Rudland; Carla J Terry; Guozheng Wang; Roger Barraclough
Journal:  Carcinogenesis       Date:  2008-09-10       Impact factor: 4.944

8.  [Activator of metastasis in cancer cells, Mst1/S100A4 protein binds to tumor suppressor protein p53].

Authors:  M Grigorian; E Lukanidin
Journal:  Genetika       Date:  2003-07

9.  Database of p53 gene somatic mutations in human tumors and cell lines.

Authors:  M Hollstein; K Rice; M S Greenblatt; T Soussi; R Fuchs; T Sørlie; E Hovig; B Smith-Sørensen; R Montesano; C C Harris
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

Review 10.  Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle.

Authors:  E A Nigg
Journal:  Bioessays       Date:  1995-06       Impact factor: 4.345

View more
  5 in total

1.  Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.

Authors:  Massimiliano Cadamuro; Gaia Spagnuolo; Luisa Sambado; Stefano Indraccolo; Giorgia Nardo; Antonio Rosato; Simone Brivio; Chiara Caslini; Tommaso Stecca; Marco Massani; Nicolò Bassi; Eugenio Novelli; Carlo Spirli; Luca Fabris; Mario Strazzabosco
Journal:  Cancer Res       Date:  2016-06-21       Impact factor: 12.701

2.  Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.

Authors:  Sarandeep S S Boyanapalli; Wenji Li; Francisco Fuentes; Yue Guo; Christina N Ramirez; Ximena-Parades Gonzalez; Douglas Pung; Ah-Ng Tony Kong
Journal:  Pharmacol Res       Date:  2016-11-03       Impact factor: 7.658

3.  Expression and clinical significance of Wee1 in colorectal cancer.

Authors:  Eivind Valen Egeland; Kjersti Flatmark; Jahn M Nesland; Vivi Ann Flørenes; Gunhild M Mælandsmo; Kjetil Boye
Journal:  Tumour Biol       Date:  2016-05-24

4.  Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.

Authors:  Kjetil Boye; Havjin Jacob; Kari-Anne M Frikstad; Jahn M Nesland; Gunhild M Maelandsmo; Olav Dahl; Arild Nesbakken; Kjersti Flatmark
Journal:  Cancer Med       Date:  2016-06-08       Impact factor: 4.452

Review 5.  S100A4 in cancer progression and metastasis: A systematic review.

Authors:  Fei Fei; Jie Qu; Mingqing Zhang; Yuwei Li; Shiwu Zhang
Journal:  Oncotarget       Date:  2017-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.